SMC approves bimekizumab for hidradenitis suppurativa treatment
The Scottish Medicines Consortium (SMC) has approved bimekizumab for adults with active moderate...
Read More
Author: John Pinching
European Commission approves ustekinumab for paediatric Crohn’s disease
Approval extends ustekinumab’s use to younger patients
Read More
Elekta and Azra AI partner to advance cancer registry operations with AI
Collaboration introduces automation to enhance efficiency
Read More
4basebio receives MHRA licence for synthetic DNA manufacture
GMP certification enables 4basebio to supply DNA for clinical trials
Read More
NICE recommends brentuximab vedotin plus AVD for Hodgkin lymphoma
Advancing care for stage 3 or 4 Hodgkin lymphoma patients
Read More- Acoramidis approved for heart condition treatment
- Genomics study launches to optimise childhood cancer care in Ireland
- UCL researchers launch congenital muscular dystrophy research programme
- Novavax shares positive real-world results for JN.1-adapted COVID-19 vaccine
- FDA approves Click’s digital therapeutic for episodic migraine
